Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 June 2021 | Story Dr Nitha Ramnath

A passion for evidence-based medicine and the notion of value in healthcare is what drives Dr Anchen Laubscher, our guest in the fifth episode of the Voices from the Free State podcast. Anchen is driven to ensure that healthcare is scientifically proven, of high quality, cost effective, and tailored to a patient’s needs.  

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.  Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them.

 

 

Google Podcasts BadgeRSS Podcasts Logo

 

Our podcast guest

Anchen joined Netcare in 2007 as an aeromedical doctor and has been with the group for almost 14 years. As Group Medical Director of Netcare Ltd, Anchen is responsible for the strategic oversight and operational execution of all clinical and quality-related matters across the different divisions of Netcare. Leading a team of subject matter experts, Anchen oversees the group’s key deliverables related to the value of care, encompassing quality outcomes, patient safety, patient experience, and episode cost efficiency, with all components of ‘value’ digitally enabled and data driven.

Anchen is a member of the Hospital Association of South Africa (HASA) subcommittee for Clinical Quality and the South African Committee of Medical Deans (SACOMD) initiative, which was constituted to address the human resource dilemma specifically related to the training of doctors in South Africa. She is a Council member of the University of the Free State, where she also serves on the Senate and holds director appointments in the Mother and Child Academic Hospital (MACAH) Foundation, the My Walk My Soul collaboration between Netcare and Adcock-Ingram and the University of Cape Town Medical Centre Ltd.  Anchen played a pioneering leadership role in South Africa’s response to the 2014 global Ebola Virus Disease (EVD) outbreak, which continues in her role as Gold Command in Netcare and as member of various national committee and advisory structures related to the COVID-19 pandemic preparedness and response. For her role in the South African EVD response, she was recognised with an honorary award from the South African Military Health Services (SAMHS).

Clinically, Anchen continues to contribute to the specialty of emergency medicine, specifically pre-hospital and aeromedicine. She continues to be involved at her alma mater through ad hoc lecturing in electives, research support at GIBS, and participating in health-care courses and conferences such as the 2020 Healthcare Industry Update and Innovation Conference.

Stay tuned for episode six to be released on 5 July 2021.

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za

Listen to all the Voices from the Free State podcasts.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept